Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 43 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 CA217923, 2 T32 ES 7324-21
NCI NIH HHS
Grant: R01 CA217923
NIEHS NIH HHS
Grant: T32 ES007324
National Institutes of Health
Grant: 5T32ES007324-04
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY
National Institutes of Health
Grant: 5R01CA217923-02
SESN2 and therapeutic effect of Isohapontigenin (ISO)
FWCI
3.13
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals